Latest News

Date Title Topic
19 Jan 2016 ESMO Workshop: Cancer Patient Advocacy Networks Driving Research
Pre-IMPAKT 2016 Training Course
12 Jan 2016 January 2016 – Image of the Month
11 Jan 2016 ESMO-ESO Course on Medical Oncology for Medical Students 2016
07 Jan 2016 New NICE Guidelines to Improve End of Life Care Palliative and supportive care
04 Jan 2016 ESMO E-Learning: Breast Cancer in Young Women
04 Jan 2016 Colorectal Cancer in Young Adults: the Focus on Hereditary Cancer Syndromes
21 Dec 2015 European Medicines Agency Recommends Two New Indications for Ramucirumab Lung and other thoracic tumours - Gastrointestinal cancers - Anticancer agents & Biologic therapy
21 Dec 2015 European Medicines Agency Recommends Granting a Conditional Marketing Authorisation for Osimertinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
21 Dec 2015 European Medicines Agency Recommends Granting a Marketing Authorisation for Necitumumab Lung and other thoracic tumours - Anticancer agents & Biologic therapy
21 Dec 2015 European Medicines Agency Recommends to Extend Therapeutic Indications for Erlotinib Lung and other thoracic tumours - Anticancer agents & Biologic therapy
21 Dec 2015 Trastuzumab-emtansine Too Costly for Use on the NHS England Breast cancer - Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
21 Dec 2015 ESMO Asia 2015 News: Pembrolizumab ‘New Standard-Of-Care’ In Advanced NSCLC After Platinum-based Chemotherapy Lung and other thoracic tumours
21 Dec 2015 ESMO Asia 2015 News: Improved Outcomes With Afatinib Versus Gefitinib In EGFR-Mutant NSCLC Lung and other thoracic tumours
20 Dec 2015 ESMO Asia 2015 News: RADIANT-4 Supports Everolimus in Neuroendocrine Tumour Patients Gastrointestinal cancers